Liver metastasis represents a critical challenge in cancer progression, with particularly complex therapeutic implications. In ovarian cancer patients, ovarian cancer liver metastasis (OCLM) marks a distinct stage of disease progression that demands specialized diagnostic and therapeutic approaches. Despite its clinical significance, guidance for OCLM management remains notably absent in current clinical practice. This comprehensive review synthesizes recent advances in the management of OCLM, with special emphasis on a resectability‐based classification system.